CANVAS Network
The Canadian National Vaccine Safety (CANVAS) Network is a national platform that monitors vaccine safety after vaccines are approved for use
These studies complement Canada's passive vaccine safety surveillance system by providing rapid information in the early stages of each vaccine campaign
Active Studies
COVID-19/FLU
The purpose of this study is to find out how often health problems occur after a COVID-19 and/or Influenza vaccine
RSV
A study on how often health problems occur after a respiratory syncytial virus (RSV) vaccine or monoclonal antibody
Study Results
The purpose of these safety surveillance studies is to find out how often health problems occur after immunizations
COVID-19/FLU
A study on how often health problems occur after a COVID-19 and/or influenza vaccine (2023-present)
COVID-19
Vaccine safety monitoring for health problems after the initial doses of the COVID-19 pandemic vaccine (2021-2022)
INFLUENZA
Vaccine safety research after pandemic vaccine campaigns, such as H1N1 Influenza vaccine (2009) and seasonal Influenza vaccines (2009-2020 and 2022)
MENB
MenB safety surveillance studies conducted following immunization with meningococcal serogroup B vaccine
MPox
MPox safety surveillance studies examined the safety of Imvamune (MPox) vaccine
RSV
A study on how often health problems occur after a respiratory syncytial virus (RSV) vaccine or monoclonal antibody
Participant Institutions and Partners
